As MAPK1, MAPK3, MAPK14 and EGFR were also in the protein functional module with the best score, we speculated that the 4 targets might be the key targets for dapagliflozin in the treatment of T2DM complicated with CVD. This evidence concerns the gene EGFR and type 2 diabetes mellitus.